LUNG DISEASES, INTERSTITIAL
Clinical trials for LUNG DISEASES, INTERSTITIAL explained in plain language.
Never miss a new study
Get alerted when new LUNG DISEASES, INTERSTITIAL trials appear
Sign up with your email to follow new studies for LUNG DISEASES, INTERSTITIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tracking a lung drug's real-world impact on breathing and cough
Disease control OngoingThis study follows 88 patients in Greece who have a progressive lung disease linked to connective tissue disorders and are taking the medication nintedanib. Researchers want to see if changes in lung function over two years are connected to changes in symptoms like shortness of b…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Real-World watch: tracking side effects of lung disease drug
Disease control OngoingThis study is monitoring the long-term safety of Ofev capsules in Japanese patients with lung disease caused by systemic scleroderma. Researchers are tracking side effects, particularly stomach and intestinal issues like diarrhea and nausea, in real-world use. The goal is to conf…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC